A Randomized Phase III Study of Metronomic vs. Intermittent Capecitabine Maintenance Therapy Following First-line Capecitabine and Docetaxel Therapy in HER2-negative Metastatic Breast Cancer
Latest Information Update: 07 Jul 2022
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel
- Indications Advanced breast cancer; Male breast cancer
- Focus Registrational; Therapeutic Use
- Acronyms CAMELLIA
- 21 Jul 2020 Planned number of patients changed from 928 to 280.
- 21 Jul 2020 Planned End Date changed from 1 Sep 2018 to 1 Jul 2021.
- 21 Jul 2020 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2020.